↓ Skip to main content

Oncotarget

Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma

Overview of attention for article published in Oncotarget, November 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 X users
facebook
1 Facebook page
video
1 YouTube creator

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
16 Mendeley
Title
Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma
Published in
Oncotarget, November 2021
DOI 10.18632/oncotarget.28077
Pubmed ID
Authors

Arvin Medhat, Alla Arzumanyan, Mark A. Feitelson

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 13%
Researcher 2 13%
Lecturer > Senior Lecturer 1 6%
Student > Master 1 6%
Unknown 10 63%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 19%
Environmental Science 1 6%
Nursing and Health Professions 1 6%
Immunology and Microbiology 1 6%
Unknown 10 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 December 2021.
All research outputs
#7,540,093
of 23,002,898 outputs
Outputs from Oncotarget
#3,765
of 14,343 outputs
Outputs of similar age
#168,852
of 505,042 outputs
Outputs of similar age from Oncotarget
#25
of 47 outputs
Altmetric has tracked 23,002,898 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 14,343 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 505,042 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.